• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 211/14 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom

Patent holdings for IPC class C07D 211/14

Total number of patents in this class: 389

10-year publication summary

21
26
27
22
26
30
24
28
25
16
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
4898
7
Incyte Corporation
1024
7
University of Pittsburgh - Of the Commonwealth System of Higher Education
3151
7
Nocion Therapeutics, Inc.
42
7
Incyte Holdings Corporation
660
6
Janssen Pharmaceutica N.V.
3392
5
Centre National de La Recherche Scientifique
10418
5
Massachusetts Institute of Technology
10057
5
Cassava Science, Inc.
13
5
BASF SE
20933
4
Immunomet Therapeutics Inc.
31
4
Modernatx, Inc.
1263
4
Toyama Chemical Co., Ltd.
102
4
Anji Pharmaceuticals Inc.
34
4
Etherna Immunotherapies NV
58
4
Libra Therapeutics, Inc.
10
4
Boehringer Ingelheim International GmbH
4650
3
Chevron U.S.A. Inc.
3955
3
JSR Corporation
2517
3
Chong Kun Dang Pharmaceutical Corp.
233
3
Other owners 295